Chronic pain involves more than just hurting. People suffering from pain often experience sadness, depression and lethargy. That's one reason opioids can be so addictive -- they not only dampen the pain but also make people feel euphoric.
What if it were possible to develop a pain killer that could curb the negative emotions associated with pain without causing euphoria? Researchers have taken a step toward that goal. Studying rodents, they have shown they can block receptors in the brain responsible for the emotional components of pain and restore the animal's motivation. Their findings could lay the groundwork for developing new, less addictive approaches to pain treatment.
"We're in the midst of an opioid epidemic, and the euphoria associated with opioids is a major driver of opioid dependence," said senior investigator. "By targeting the emotional aspects of pain, we hope to make pain less debilitating so that patients won't crave the emotional high they get from opioids."
Opioid painkillers, such as morphine, oxycodone and fentanyl, target receptors on brain cells called mu opioid receptors. In contrast, the researchers studied kappa opioid receptors, which operate very differently. Activating the kappa receptor makes people feel depressed, sad and unmotivated. So the authors thought that by blocking those receptors, they also might dampen the negative emotions associated with pain. Their findings are published in the journal Neuron.
Some of the rats in the study had been injected in a paw with a substance that causes persistent inflammation. To measure the emotional effects of that pain, the researchers used a rewarding task in which the animals could work for sugar as a way to measure motivation. After being taught to push a lever to get sugar, most rats will keep pushing. In these experiments, the animals had to push the lever progressively more each time they wanted a pellet of sucrose.
"When the animals experienced pain, they were less motivated to work to obtain the reward," said first author. "It's often the same for people in pain who don't get as much pleasure from daily activities they usually enjoy."
But when the rats with inflamed paws were treated with a compound to block kappa opioid receptors in their brains, the animals recovered the motivation to obtain the sugar, and pushed the lever as often as those who did not have inflamed paws.
In addition, the researchers using small animal positron emission tomography (PET) imaging to assess the activity of kappa opioid receptors in the animals' brains. They were able to demonstrate that when rats were in pain, their kappa opioid receptors were very active in a part of the brain -- the nucleus accumbens -- linked to emotion.
The researchers dampened this kappa opioid receptor activity by blocking the release of a natural stimulator of kappa opioid receptors called dynorphin -- which is produced in the brain and is kind of like the inverse of the endorphins released by activities such as exercise.
"By blocking dynorphin release, we were able to restore motivation in the animals despite the fact that we did not completely eliminate their pain," the author said.
The researchers acknowledge it's a long journey from rodents to people. But they already have preliminary PET data from people, suggesting it may be possible to influence kappa opioid receptors and potentially prevent the sadness and lack of motivation that can accompany physical pain. They believe that by attacking pain's emotional properties, without affecting the useful element of the pain response that can protect injuries from further damage, it may be possible to improve quality of life for pain patients without having to use any, or as many, habit-forming opioid pain killers.
https://medicine.wustl.edu/news/blunting-the-emotional-component-of-pain/
https://www.cell.com/neuron/pdfExtended/S0896-6273(19)30164-3
Latest News
Metabolic rewiring promotes…
By newseditor
Posted 18 Apr
A drug to prevent flu-induc…
By newseditor
Posted 18 Apr
New origin of deep brain waves
By newseditor
Posted 17 Apr
Starving cells hijack prote…
By newseditor
Posted 17 Apr
Miniature battery-free epid…
By newseditor
Posted 17 Apr
Other Top Stories
Tumors shrank with cell cycle-blocking drugs!
Read more
Are very low LDL cholesterol levels beneficial for patients?
Read more
Functional neuronal regeneration from Müller glia in adult mice
Read more
Mechanism of lymphatic vessel growth during infection!
Read more
Patient plays saxophone while surgeons remove brain tumor
Read more
Protocols
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Modular dual-color BiAD sen…
By newseditor
Posted 31 Mar
Publications
How does the microbiota con…
By newseditor
Posted 18 Apr
The integrated stress respo…
By newseditor
Posted 18 Apr
The immunobiology of herpes…
By newseditor
Posted 17 Apr
Circulating microbiome DNA…
By newseditor
Posted 17 Apr
Spindle oscillations in com…
By newseditor
Posted 17 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar